manilatimes3h
Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency
Anbio Biotechnology ('Anbio'), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence ...
Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch
Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...
Medtech test developer Anbio files for $9M US IPO
Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public ...
Anbio Biotechnology Files for 1.6 Million-Share IPO
Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...
360dx5d
German IVD Firm Anbio Biotechnology Files for IPO
NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...